Tempest Therapeutics Inc. (TPST)

AI Score

Unlock

0.66

-0.06 (-8.14%)

At close: Apr 04, 2025, 11:09 AM

Tempest Therapeutics Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	295K	653K	277K	9.73M	n/a	n/a	n/a
Cost of Revenue	n/a	381K	1.81M	1.27M	815K	1.05M	32K	28K	5.4M	2.25M	n/a	n/a	n/a	n/a
Gross Profit	n/a	-381K	-1.81M	-1.27M	-815K	-1.05M	-32K	267K	-4.75M	-1.97M	9.73M	n/a	n/a	n/a
Operating Income	n/a	-29.16M	-34.64M	-26.99M	-19.3M	-45.4M	-23.12M	-20.48M	-75.61M	-72M	-47.93M	-29.13M	-13.53M	-2.62M
Interest Income	n/a	1.11M	549K	1.28K	90K	264K	n/a	n/a	n/a	n/a	n/a	n/a	19K	n/a
Pretax Income	-41.84M	-29.49M	-35.71M	-28.3M	-19.21M	-44.57M	-27.18M	-84.59M	-82.06M	-73.14M	-49.52M	-29.04M	-13.51M	-2.62M
Net Income	-41.84M	-29.49M	-36.78M	-29.55M	-19.12M	-44.57M	-27.19M	-84.58M	-82.26M	-73.22M	-49.52M	-29.04M	-13.51M	-2.73M
Selling & General & Admin	13.55M	11.66M	12.11M	9.82M	4.91M	16.5M	8.66M	5.93M	49.22M	51.59M	26.15M	13.33M	7.21M	1.45M
Research & Development	28.48M	17.5M	22.53M	17.17M	14.39M	27.84M	14.43M	14.53M	21.64M	18.43M	21.78M	15.8M	6.32M	1.17M
Other Expenses	n/a	n/a	549K	-34K	n/a	n/a	n/a	4.03M	5.4M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	42.03M	29.16M	34.64M	26.99M	19.3M	44.35M	23.08M	20.45M	70.86M	70.03M	47.93M	29.13M	13.53M	2.62M
Interest Expense	-1.32M	1.45M	1.62M	1.28M	n/a	n/a	134K	n/a	659K	436K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	16.5M	-3.79M	-21.82M	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	29.16M	34.64M	26.99M	19.3M	45.4M	23.12M	20.48M	76.27M	72.28M	47.93M	29.13M	13.53M	2.62M
Income Tax Expense	n/a	n/a	1.07M	1.25M	-90K	1K	-169K	67K	201K	75K	-1.59M	90K	n/a	n/a
Shares Outstanding (Basic)	27.9M	15.42M	11.55M	3.79M	31.21K	913.78K	103.14K	1.17K	142.88K	120.38K	100.65K	100.65K	n/a	n/a
Shares Outstanding (Diluted)	27.9M	15.42M	11.55M	3.79M	31.21K	913.78K	103.14K	1.17K	142.88K	120.38K	100.65K	100.65K	n/a	n/a
EPS (Basic)	-1.5	-1.91	-3.18	-7.8	-612.56	-48.77	-263.65	-72.41K	-575.73	-608.25	-491.98	-288.55	-2.33	n/a
EPS (Diluted)	-1.5	-1.91	-3.18	-7.8	-612.56	-48.77	-263.65	-72.41K	-575.73	-608.25	-491.98	-288.55	-2.33	n/a
EBITDA	n/a	-28.78M	-32.28M	-25.72M	-18.39M	-43.52M	-27.01M	-84.27M	-79.82M	-71.86M	-49.07M	-28.81M	-13.53M	-2.62M
EBIT	n/a	-29.16M	-34.09M	-26.99M	-19.21M	-44.57M	-27.04M	-84.3M	-82.06M	-73.14M	-49.52M	-29.04M	-13.51M	-2.62M
Depreciation & Amortization	n/a	381K	1.81M	1.27M	815K	1.05M	32K	28K	2.24M	1.29M	450K	231K	n/a	n/a